Moderna to deliver up to 500 million doses of vaccine to Covax

Moderna Inc. agreed to provide up to 500 million doses of your vaccine against covid-19 at the global mechanism Covax (Center for Global Access to Covid-19 Vaccines) to boost the global vaccination effort, but only a small fraction of shipments are expected to arrive this year.

Moderna joins developers such as AstraZeneca Plc, Pfizer Inc. and Johnson & Johnson to provide help Covax, who suffered setbacks in his attempt to helping low-income countries. Last week, the World Health Organization (WHO) has approved the vaccine for emergency use, making it eligible for Covax.

Covax faced a series of funding difficulties, delivery delays and other obstacles in a crucial campaign to reduce the vaccine access gap. While India In the face of a devastating resurgence of the disease, concerns are growing for many countries around the world that are lagging behind their richer peers.

Last year, rich countries bought vaccines from Moderna and other pharmaceutical companies, and the United States alone has already administered more than 240 million doses. As, Covax has shipped around 50 million doses to more than 120 countries and the territories, according to data up to the end of April.

Covax: how many doses allocated until May for Argentina

Moderna’s Anticovid Vaccine Figures

the Moderna messenger RNA vaccine deliveries to Covax to begin in Q4, and there will be 34 million of the doses available in 2021according to the Global Alliance for Vaccines and Immunization (GAVIi), one of the partners in the initiative.

The US pharmaceutical sector will supply up to 466 million doses in 2022 and, potentially, it will provide access to vaccines designed to fight viral variants in the future. Moderna CEO Stephane Bancel last week said he was deeply concerned about variant outbreaks in countries like South America and India.

Terms of the deal with GAVI were not disclosed, although Moderna said it would offer the vaccine to “lowest possible price“to the company.

GAVI said it is looking to increase 2,000 million US dollars by June for additional doses covering up to 30% of the population in 92 low-income economies.

Covax is led by GAVI, WHO and the Coalition for Epidemic Preparedness Innovations (CEPI), and also works with organizations such as UNICEF.